Michael Gunnar Knell
Known title: CSVP&Chief Accounting OfficerCIK: 0001543779
Associated companies
Transaction History
| CRL | ▼ Sell | Open Market | 213 | $56K | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 620 | $164K | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 482 | $128K | 8/6/2026 | View on chart |
| CRL | ▲ Buy | Option Exercise | 404 | $73K | 8/6/2026 | View on chart |
| CRL | ▲ Buy | Option Exercise | 1,205 | $234K | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 1,274 | $330K | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 901 | $235K | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 810 | $212K | 8/6/2026 | View on chart |
| CRL | ▲ Buy | Option Exercise | 736 | $153K | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 404 | $104K | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 1,205 | $312K | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Open Market | 736 | $190K | 8/6/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 48 | $9K | 5/31/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 152 | $27K | 5/30/2026 | View on chart |
| CRL | ▲ Buy | Grant | 1,837 | $332K | 5/29/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 37 | $6K | 5/27/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 50 | $8K | 5/26/2026 | View on chart |
| CRL | ▲ Buy | Grant | 1,668 | $0 | 1/30/2026 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 526 | $111K | 1/30/2026 | View on chart |
| CRL | ▲ Buy | Grant | 2,926 | $500K | 11/6/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 225 | $31K | 6/1/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 48 | $7K | 5/31/2025 | View on chart |
| CRL | ▲ Buy | Grant | 2,064 | $280K | 5/30/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 25 | $3K | 5/28/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 37 | $5K | 5/27/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 50 | $7K | 5/26/2025 | View on chart |
| CRL | ▲ Buy | Grant | 811 | $0 | 1/31/2025 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 282 | $47K | 1/31/2025 | View on chart |
| CRL | ▲ Buy | Grant | 648 | $0 | 5/31/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 36 | $8K | 5/29/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 24 | $5K | 5/28/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 37 | $8K | 5/27/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 50 | $11K | 5/26/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 808 | $216K | 3/8/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 1,750 | $457K | 3/4/2024 | View on chart |
| CRL | ▼ Sell | Open Market | 1,000 | $261K | 3/4/2024 | View on chart |
| CRL | ▲ Buy | Grant | 968 | $0 | 1/29/2024 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 326 | $72K | 1/29/2024 | View on chart |
| CRL | ▲ Buy | Option Exercise | 1,471 | $213K | 8/10/2023 | View on chart |
| CRL | ▼ Sell | Open Market | 1,471 | $319K | 8/10/2023 | View on chart |
| CRL | ▲ Buy | Grant | 1,528 | $0 | 6/1/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 36 | $7K | 5/29/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 24 | $5K | 5/28/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 36 | $7K | 5/27/2023 | View on chart |
| CRL | ▲ Buy | Grant | 670 | $0 | 5/26/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 51 | $12K | 2/22/2023 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 645 | $158K | 1/27/2023 | View on chart |
| CRL | ▲ Buy | Grant | 2,096 | $0 | 1/27/2023 | View on chart |
| CRL | ▲ Buy | Option Exercise | 855 | $93K | 11/16/2022 | View on chart |
| CRL | ▼ Sell | Open Market | 855 | $213K | 11/16/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 54 | $13K | 5/29/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 37 | $9K | 5/28/2022 | View on chart |
| CRL | ▲ Buy | Grant | 491 | $0 | 5/27/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 56 | $16K | 2/23/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 51 | $15K | 2/22/2022 | View on chart |
| CRL | ▲ Buy | Grant | 2,741 | $0 | 1/28/2022 | View on chart |
| CRL | ▼ Sell | Tax Withholding | 826 | $258K | 1/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
CRL Analyst Targets Rise After UBS Reinstates Coverage
Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.
CRL Analyst Targets Rise After UBS Reinstates Coverage. Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.